Inventor · disambiguated record
Lorin Roskos
Also filed as: ROSKOS LORIN
12 granted patents·14 pending applications·93 citations·filing 2003–2024
90Inventor score
Top patents by PatentIndex Score
26 records- 0190US7318925B2Methods of use for antibodies against parathyroid hormoneAMGEN FREMONT INC·Filed 2004·Granted Jan 15, 2008·30 cites·27 claims
- 0290US7288253B2Antibodies directed to parathyroid hormone (PTH) and uses thereofAMGEN FREMONT INC·Filed 2003·Granted Oct 30, 2007·32 cites·16 claims
- 0388US12224043B2Methods for determining treatment for cancer patientsMEDIMMUNE LLC·Filed 2023·Granted Feb 11, 2025·1 cites·20 claims
- 0487US11798653B2Methods for determining treatment for cancer patientsMEDIMMUNE LLC·Filed 2019·Granted Oct 24, 2023·5 cites·11 claims
- 0586US12060429B2Method of treating type 1 interferon (IFN)-mediated disease using a subcutaneous dosing regimen comprising anifrolumabASTRAZENECA AB·Filed 2023·Granted Aug 13, 2024·2 cites·10 claims
- 0685US10829557B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2019·Granted Nov 10, 2020·2 cites·9 claims
- 0784US9493570B2Fixed dosage regimens for anti-type I interferon receptor (IFNAR) antibodiesMEDIMMUNE LLC·Filed 2013·Granted Nov 15, 2016·8 cites·1 claims
- 0880US9441037B2Methods for reducing exacerbation rates of asthma using benralizumabMEDIMMUNE LLC·Filed 2014·Granted Sep 13, 2016·4 cites·9 claims
- 0977US9441047B2Methods for improving asthma symptoms using benralizumabMEDIMMUNE LLC·Filed 2014·Granted Sep 13, 2016·3 cites·9 claims
- 1077US9441046B2Methods for increasing forced expiratory volume in asthmatics using benralizumabMEDIMMUNE LLC·Filed 2014·Granted Sep 13, 2016·3 cites·10 claims
- 1176US10336823B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2014·Granted Jul 2, 2019·3 cites·18 claims
- 1273US2024400699A1Anti-ifnar1 dosing regime for subcutaneous injectionASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1372US2024360231A1DoseASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1469US11827706B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2020·Granted Nov 28, 2023·0 cites·20 claims
- 1565US2022340669A1DoseASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 1661US2025002590A1Treatment of lupus nephritis with anti-type i inf receptor antibody anifrolumabASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 1761US2022348669A1Treatment of lupus nephritisASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 1861US2024150469A1Anti-b7-h1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 1957US2025002589A1Treatment of cutaneous lupus erythematousASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 2056US2020123262A1Methods For Treating Chronic Obstructive Pulmonary Disease Using BenralizumabASTRAZENECA AB·Filed 2019·Application pending·0 cites
- 2156US2015104447A1Methods for treating chronic obstructive pulmonary disease using benralizumabMEDIMMUNE LLC·Filed 2014·Application pending·0 cites
- 2252US2018291108A1Methods For Treating Chronic Obstructive Pulmonary Disease Using BenralizumabASTRAZENECA AB·Filed 2017·Application pending·0 cites
- 2351US2005084488A1Asparagine deaminase catalytic antibodiesFiled 2004·Application pending·0 cites
- 2448US2017107291A1Methods for treating chronic obstructive pulmonary disease using benralizumabMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 2544US2017198049A1Methods for reducing exacerbation rates of asthma using benralizumabASTRAZENECA AB·Filed 2016·Application pending·0 cites
- 2637US2013281876A1Therapies for improving pulmonary functionFAGGIONI RAFFAELLA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lorin Roskos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →